Navigation Links
Infectious Disease Research Institute Receives Grant from the Bill & Melinda Gates Foundation for Adjuvant Access and Development
Date:12/3/2007

SEATTLE, Dec. 4 /PRNewswire/ -- The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit scientific research institute, announced today that it has received a $29,947,850 five year grant from the Bill & Melinda Gates Foundation. The grant will be used to provide adjuvants (essential components for many vaccines) for priority malaria vaccine candidates. Advances arising from this project are likely also to facilitate development of vaccines against other neglected diseases.

Adjuvants are vaccine components that, when appropriately formulated and combined with an antigen, direct the immune system to give an effective response while boosting the potency and longevity of the specific immune responses. Most adjuvants are owned by large pharmaceutical companies and not easily accessible to researchers developing vaccines for neglected diseases. IDRI seeks to provide the public sector with safe, effective, low-cost adjuvants through component testing and licensing, product improvement, development of adjuvant-antigen formulations, and the creation of an adjuvant library.

With this grant, IDRI will focus on adjuvants for malaria vaccines. Because malaria parasites have a complex life cycle, creating an effective vaccine is a major scientific challenge. Worldwide, every year between 350 million and 500 million people are infected with malaria and more than 1 million die from this preventable disease. To accelerate the fight against malaria, IDRI will obtain access to adjuvants with proven clinical potential in malaria vaccines and will develop next-generation adjuvant formulations for malaria vaccine candidates.

"This grant enables IDRI to help advance the development of malaria vaccines," said Dr. Steven Reed, Founder and Head of IDRI's Research and Development Program. "We are honored that the Gates Foundation has provided this opportunity and look forward to working with researchers in the field of malaria."

IDRI, in partnership with the World Health Organization in Geneva, will work closely with the PATH Malaria Vaccine Initiative and other agencies and investigators to select priority malaria antigens for preliminary development and testing of these adjuvant formulations.

About IDRI

IDRI is a non-profit organization committed to developing technologies to treat "neglected" diseases that place a significant burden on those living in the developing world. IDRI achieves its mission by working closely with industry, universities, and hospitals in developed and developing countries, government and private funding agencies, and the World Health Organization. For more information, go to http://www.idri.org.


'/>"/>
SOURCE The Infectious Disease Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
2. Infectious diseases experts applaud bill against bad bugs
3. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
4. Einstein scientists treat cancer as an infectious disease -- with promising results
5. Northwestern exposing most deadly infectious diseases in 3-D
6. Southern Research Institute Names Vladimir Yamshchikov Director of Infectious Disease Research Department in Birmingham
7. Study shows suppressing herpes virus may reduce infectiousness of HIV
8. Infectious Diseases Institute Appoints Alex Coutinho, M.D as Executive Director
9. Smoking may strongly increase long-term risk of eye disease
10. Pot bellies linked to early signs of cardiovascular disease
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 2016 , ... Boar’s Head Brand®, one of the nation’s leading providers of ... Take the stress out of your party preparation – follow these easy, yet delicious ... of the game. , “The key to hosting a successful game-day party is creating ...
(Date:2/5/2016)... Atlanta, Georgia (PRWEB) , ... February 05, 2016 , ... ... pleased to announce their 2nd Annual No Cost Dental Day to individuals in need. ... 4pm. The purpose of this No Cost Dental Day is to provide dental care ...
(Date:2/5/2016)... ... 05, 2016 , ... Colorize is a web theme package created ... next using Colorize's dynamic moving camera. Colorize is perfect for personal and web related ... environment with 1 to 5 focus points per scene, stage floor scene presets that ...
(Date:2/5/2016)... ... 2016 , ... California Mobile Kitchens , a company ... latest mobile kitchen model, featuring customizable stainless steel interiors and a new, 26-foot ... use anywhere in the U.S. Many of their units can be seen at ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... Men’s Soccer Career Development event in New York City on Thursday, January 21, ... and CEO of Mediacom, (both alumnus of the varsity Columbia soccer program) spoke ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... -- The Senior Care Pharmacy Coalition (SCPC) today commended ... Jason Chaffetz (R-UT) and Ranking Member Elijah ... "Developments in the Prescription Drug Market," to examine ... abusive pharmacy benefit manager (PBM) pricing practices. ... Elijah Cummings (D-MD) are diligent, serious lawmakers committed ...
(Date:2/4/2016)... , Feb. 4, 2016   Bernstein Liebhard LLP ... filed in the United States District Court for the District ... class (the "Class") consisting of all persons or entities who ... "Company") (NASDAQ: INSY ) from March 3, 2015 through ... and certain of its officers with violations of the Securities ...
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
Breaking Medicine Technology: